Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans
Y Hirooka,
K Egashira,
T Imaizumi,
T Tagawa,
H Kai,
M Sugimachi,
and
A Takeshita
Research Institute of Angiocardiology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
OBJECTIVES. The goal of this study was to determine whether the effect of L-arginine on endothelium-dependent vasodilation evoked with acetylcholine differs between the coronary and forearm vasculatures in humans. BACKGROUND. Administration of L-arginine, a substrate in the production of endothelium-derived nitric oxide, may stimulate the release of nitric oxide. METHODS. Seven patients with normal coronary angiograms and seven with mild coronary artery disease and hypertension underwent coronary arteriography and an intracoronary Doppler catheter technique, and the diameter of the large epicardial coronary artery and coronary blood flow were measured. Forearm blood flow was measured by use of a strain gauge plethysmograph. RESULTS. Before L-arginine administration, acetylcholine (1 to 30 micrograms/min) increased coronary blood flow with modest vasoconstriction of a large coronary artery. Acetylcholine (4 to 24 micrograms/min) also increased forearm blood flow. The acetylcholine-induced increases in coronary and forearm blood flow were significantly less in patients with coronary artery disease than in control patients. Intracoronary infusion of L-arginine at 50 mg/min did not alter responses of the large coronary artery diameter or coronary blood flow to acetylcholine in either group. In contrast, L-arginine at 10 mg/min significantly (p < 0.01) augmented the forearm blood flow response to acetylcholine (4 to 24 micrograms/min) to a similar extent in the two groups. CONCLUSIONS. The effect of L-arginine on acetylcholine-induced vasodilation differs between the coronary and forearm vasculatures in humans. It is suggested that impaired acetylcholine-induced coronary and forearm vasodilation in patients with coronary artery disease and hypertension may not be related to a limited availability of L-arginine.
This article has been cited by other articles:

|
 |

|
 |
 
A. G. Hays, G. A. Hirsch, S. Kelle, G. Gerstenblith, R. G. Weiss, and M. Stuber
Noninvasive Visualization of Coronary Artery Endothelial Function in Healthy Subjects and in Patients With Coronary Artery Disease
J. Am. Coll. Cardiol.,
November 9, 2010;
56(20):
1657 - 1665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bai, L. Sun, T. Yang, K. Sun, J. Chen, and R. Hui
Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials
Am J Clin Nutr,
January 1, 2009;
89(1):
77 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Terashima, C. H. Meyer, B. G. Keeffe, E. J. Putz, E. de la Pena-Almaguer, P. C. Yang, B. S. Hu, D. G. Nishimura, and M. V. McConnell
Noninvasive assessment of coronary vasodilation using magnetic resonance angiography
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
104 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Cohn, A. A. Quyyumi, N. K. Hollenberg, and K. A. Jamerson
Surrogate Markers for Cardiovascular Disease: Functional Markers
Circulation,
June 29, 2004;
109(25_suppl_1):
IV-31 - IV-46.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Agatisa, R. B. Ness, J. M. Roberts, J. P. Costantino, L. H. Kuller, and M. K. McLaughlin
Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk
Am J Physiol Heart Circ Physiol,
April 1, 2004;
286(4):
H1389 - H1393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Tousoulis, G J Davies, C Tentolouris, T Crake, G Goumas, C Stefanadis, and P Toutouzas
Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries
Heart,
May 1, 2003;
89(5):
531 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Haynes
Triglyceride-Rich Lipoproteins and Vascular Function
Arterioscler Thromb Vasc Biol,
February 1, 2003;
23(2):
153 - 155.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tousoulis, C. Antoniades, C. Tentolouris, G. Goumas, C. Stefanadis, and P. Toutouzas
L-Arginine in cardiovascular disease: dream or reality?
Vascular Medicine,
August 1, 2002;
7(3):
203 - 211.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Houghton, E. F. Philbin, D. S. Strogatz, M. T. Torosoff, S. A. Fein, P. A. Kuhner, V. E. Smith, and A. A. Carr
The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine
J. Am. Coll. Cardiol.,
April 17, 2002;
39(8):
1314 - 1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Maxwell, M. P. Zapien, G. L. Pearce, G. MacCallum, and P. H. Stone
Randomized trial of a medical food for the dietary management of chronic, stable angina
J. Am. Coll. Cardiol.,
January 2, 2002;
39(1):
37 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Tousoulis, G J Davies, C Tentolouris, G Goumas, C Stefanadis, and P Toutouzas
Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque
Heart,
September 1, 2001;
86(3):
296 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. New, S. J. Duffy, R. W. Harper, and I. T. Meredith
Estrogen improves acetylcholine-induced but not metabolic vasodilation in biological males
Am J Physiol Heart Circ Physiol,
December 1, 1999;
277(6):
H2341 - H2347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Tousoulis, C Tentolouris, T Crake, G Katsimaglis, C Stefanadis, P Toutouzas, and G J Davies
Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P
Heart,
May 1, 1999;
81(5):
505 - 511.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Bottcher, H. E. Botker, H. Sonne, T. T. Nielsen, and J. Czernin
Endothelium-Dependent and -Independent Perfusion Reserve and the Effect of L-arginine on Myocardial Perfusion in Patients With Syndrome X
Circulation,
April 13, 1999;
99(14):
1795 - 1801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Newby, R. A. Wright, C. Labinjoh, C. A. Ludlam, K. A. A. Fox, N. A. Boon, and D. J. Webb
Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking : A Mechanism for Arterial Thrombosis and Myocardial Infarction
Circulation,
March 23, 1999;
99(11):
1411 - 1415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Dakak, S. Husain, D. Mulcahy, N. P. Andrews, J. A. Panza, M. Waclawiw, W. Schenke, and A. A. Quyyumi
Contribution of Nitric Oxide to Reactive Hyperemia : Impact of Endothelial Dysfunction
Hypertension,
July 1, 1998;
32(1):
9 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Egashira, Y. Hirooka, T. Kuga, M. Mohri, and A. Takeshita
Effects of L-Arginine Supplementation on Endothelium-Dependent Coronary Vasodilation in Patients With Angina Pectoris and Normal Coronary Arteriograms
Circulation,
July 15, 1996;
94(2):
130 - 134.
[Abstract]
[Full Text]
|
 |
|
|